Daiichi Sankyo (TSE: 4568) will present new clinical research across its oncology portfolio with more than 20 abstracts in ...

Daiichi Sankyo and MSD have announced the first subject dosing in the Phase III Ideate-Esophageal01 trial, assessing the ...

IHH Healthcare said on Tuesday its unit has filed a petition in a Tokyo court to revise damages sought from Japan's Daiichi ...

Tumors with low- and ultra-low levels of a protein called HER2 are treatable with Enhertu, but harder to identify. New ...

Merck MRK and Japan’s Daiichi Sankyo announced the dosing of the first patient in the phase III IDeate-Esophageal01 study ...

The lawsuit, first announced on Nov 14, 2023, arose from alleged obstruction by the Japanese drug maker against NTK’s efforts ...

The revised claim stems from NTK’s allegations that Daiichi Sankyo obstructed its 2018 open offer to acquire shares in ...

Malaysia's IHH Healthcare has significantly increased its damage claim against Japan's Daiichi Sankyo in Tokyo District Court ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Malaysia's IHH Healthcare is seeking JPY 200 billion (Rs 11,800 crore) in damages from Japan's Daiichi Sankyo for blocking ...

IHH Healthcare's subsidiary NTK raises damages claim against Daiichi Sankyo to Rs 11,800 crore for obstructing its Fortis ...

IHH's Singapore-based indirect subsidiary Northern TK Ventures (NTK) has approached the Tokyo District Court seeking to amend ...